BTIG Believes Misonix (MSON) Still Has Room to Grow

In a report released yesterday, Ryan Zimmerman from BTIG maintained a Buy rating on Misonix (MSON – Research Report), with a price target of $26.00. The company's shares closed last Thursday at $23.84, close to its 52-week high of $24.42. According to TipRanks.com, Zimmerman is a 5-star analyst with an average return of 29.1% and a 64.1% success rate. Zimmerman covers the Healthcare sector, focusing on stocks such as Tactile Systems Technology, Zimmer Biomet Holdings, and Staar Surgical Company. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Misonix with a $24.50 average price target. See today’s analyst top recommended stocks >> Misonix's market cap is currently $417.6M and has a P/E ratio of -20.60. The company has a Price to Book ratio of 40.97. TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities. Misonix, Inc. is a medical device company, which engages in the design, development, manufacture and marketing of therapeutic ultrasonic medical devices. Its products include the bonescalpel cutting system, which is used for surgical procedures of the spine and on maxillofacial procedures; the sonastar surgical aspirator, which is used to emulsify and remove soft and hard tumors; the sonicone wound cleansing and debridement system, which offers tissue specific debridement and cleansing of wounds for effective removal of devitalized tissue and fibrin deposits while sparing viable cells. The company's ultrasonic medical devices are used in the following surgeries: spine, neuro, orthopedic, wound debridement, cosmetic, laparoscopic, and medical applications. The company was founded by Howard Alliger in 1959 and is headquartered in Farmingdale, NY. Read More on MSON: William Blair Reaffirms Their Hold Rating on SPS Commerce (SPSC) Cubesmart (CUBE) Gets a Buy Rating from BMO Capital New Sell Rating for International Paper Co (IP), the Energy Giant Chemours Company (CC) Received its Third Buy in a Row Needham Remains a Buy on Teleflex (TFX) The post BTIG Believes Misonix (MSON) Still Has Room to Grow appeared first on TipRanks Financial Blog.

In a report released yesterday, Ryan Zimmerman from BTIG maintained a Buy rating on Misonix (MSON – Research Report), with a price target of $26.00. The company's shares closed last Thursday at $23.84, close to its 52-week high of $24.42.

According to TipRanks.com, Zimmerman is a 5-star analyst with an average return of 29.1% and a 64.1% success rate. Zimmerman covers the Healthcare sector, focusing on stocks such as Tactile Systems Technology, Zimmer Biomet Holdings, and Staar Surgical Company.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Misonix with a $24.50 average price target.

Misonix's market cap is currently $417.6M and has a P/E ratio of -20.60. The company has a Price to Book ratio of 40.97.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Misonix, Inc. is a medical device company, which engages in the design, development, manufacture and marketing of therapeutic ultrasonic medical devices. Its products include the bonescalpel cutting system, which is used for surgical procedures of the spine and on maxillofacial procedures; the sonastar surgical aspirator, which is used to emulsify and remove soft and hard tumors; the sonicone wound cleansing and debridement system, which offers tissue specific debridement and cleansing of wounds for effective removal of devitalized tissue and fibrin deposits while sparing viable cells. The company's ultrasonic medical devices are used in the following surgeries: spine, neuro, orthopedic, wound debridement, cosmetic, laparoscopic, and medical applications. The company was founded by Howard Alliger in 1959 and is headquartered in Farmingdale, NY.

Read More on MSON:

  • William Blair Reaffirms Their Hold Rating on SPS Commerce (SPSC)
  • Cubesmart (CUBE) Gets a Buy Rating from BMO Capital
  • New Sell Rating for International Paper Co (IP), the Energy Giant
  • Chemours Company (CC) Received its Third Buy in a Row
  • Needham Remains a Buy on Teleflex (TFX)

The post BTIG Believes Misonix (MSON) Still Has Room to Grow appeared first on TipRanks Financial Blog.

Source : Tip Ranks More   

What's Your Reaction?

like
0
dislike
0
love
0
funny
0
angry
0
sad
0
wow
0

Next Article

William Blair Sticks to Its Buy Rating for Microstrategy (MSTR)

William Blair analyst Kamil Mielczarek maintained a Buy rating on Microstrategy (MSTR – Research Report) yesterday. The company's shares closed last Thursday at $625.01. According to TipRanks.com, Mielczarek is ranked #4936 out of 7609 analysts. Currently, the analyst consensus on Microstrategy is a Hold with an average price target of $583.33. See today’s analyst top recommended stocks >> The company has a one-year high of $1315.00 and a one-year low of $115.87. Currently, Microstrategy has an average volume of 808.7K. TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities. MicroStrategy, Inc. engages in the provision of enterprise analytics and mobility software. It designs, develops, markets, and sells software platform through licensing arrangements and cloud-based subscriptions and related services. Its flagship platform, MicroStrategy 10, consists of the MicroStrategy Analytics, MicroStrategy Mobile, and Usher brands. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989 and is headquartered in Vienna, VA. Read More on MSTR: BTIG Believes Misonix (MSON) Still Has Room to Grow William Blair Reaffirms Their Hold Rating on SPS Commerce (SPSC) Cubesmart (CUBE) Gets a Buy Rating from BMO Capital New Sell Rating for International Paper Co (IP), the Energy Giant Chemours Company (CC) Received its Third Buy in a Row The post William Blair Sticks to Its Buy Rating for Microstrategy (MSTR) appeared first on TipRanks Financial Blog.

William Blair analyst Kamil Mielczarek maintained a Buy rating on Microstrategy (MSTR – Research Report) yesterday. The company's shares closed last Thursday at $625.01.

According to TipRanks.com, Mielczarek is ranked #4936 out of 7609 analysts.

Currently, the analyst consensus on Microstrategy is a Hold with an average price target of $583.33.

The company has a one-year high of $1315.00 and a one-year low of $115.87. Currently, Microstrategy has an average volume of 808.7K.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

MicroStrategy, Inc. engages in the provision of enterprise analytics and mobility software. It designs, develops, markets, and sells software platform through licensing arrangements and cloud-based subscriptions and related services. Its flagship platform, MicroStrategy 10, consists of the MicroStrategy Analytics, MicroStrategy Mobile, and Usher brands. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989 and is headquartered in Vienna, VA.

Read More on MSTR:

  • BTIG Believes Misonix (MSON) Still Has Room to Grow
  • William Blair Reaffirms Their Hold Rating on SPS Commerce (SPSC)
  • Cubesmart (CUBE) Gets a Buy Rating from BMO Capital
  • New Sell Rating for International Paper Co (IP), the Energy Giant
  • Chemours Company (CC) Received its Third Buy in a Row

The post William Blair Sticks to Its Buy Rating for Microstrategy (MSTR) appeared first on TipRanks Financial Blog.

Source : Tip Ranks More   

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.